Zacks Investment Research on MSN18m
Novo Nordisk Lowers Wegovy Costs for Cash-Pay Patients, Stock Up 4%
Novo Nordisk NVO announced that it is launching a new direct-to-patient online pharmacy called NovoCare, which will offer its ...
BT Exclusive: We aim to compete cross all segments in obesity treatments, says Camilla Sylvest of Novo Nordisk
In an exclusive conversation with Business Today, Camilla Sylvest, Executive Vice President, Commercial Strategy & Corporate ...
World experts say immediate government action could prevent rising obesity rates
A new global study published in The Lancet journal is sounding the alarm on worldwide obesity rates. The Lancet predicts that by 2050, over 50% of adults will be overweight, with 1 in 3 young adults ...
mlive29m
Popular weight-loss drugs get cheaper: Novo Nordisk and Eli Lilly cut prices
Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...
Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects
A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as ...
Medscape51m
Is Intermittent Fasting Worth Considering for Your Patients?
Studies suggest types of fasting can lead to moderate weight loss and other health benefits in overweight and obese people, ...
STAT55m
We’re reading about an FDA quality lab lease, Marty Makary’s confirmation hearing, and more
The Trump Administration reversed course on plans to terminate the lease of a major Food and Drug Administration quality lab ...
Obesity will affect over half of adults in 25 years, study predicts
Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much worse it could get. A team of researchers found that in 2021, one billion men ...